AstraZeneca made headlines on Tuesday with its announcement to pull back its COVID-19 vaccine from distribution worldwide. The decision, as reported by The Telegraph, stemmed from the availability of newer vaccines deemed more effective against the virus. The pharmaceutical company clarified that the move was purely commercial, attributing it to a surplus of updated COVID-19 vaccines currently on the market.